Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-091675 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
112.20% · OPTIONAL · VALID
Capex intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.12% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.37% · OPTIONAL · VALID
Revenue growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
4.96% · CORE · VALID
Inventory pressure 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
54.43% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
25.20% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.93% · CORE · VALID
R&D intensity 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.57% · OPTIONAL · VALID
SBC intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.59% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 116.19%
Current 112.20%
Delta -3.99% Capex Intensity Increased
Previous 4.22%
Current 5.12%
Delta 0.90% Cash Generation Increased
Previous 17.27%
Current 20.37%
Delta 3.10% Growth Increased
Previous -1.36%
Current 4.96%
Delta 6.31% Inventory Pressure Increased
Previous 54.07%
Current 54.43%
Delta 0.36% Margin Increased
Previous 24.14%
Current 25.20%
Delta 1.06% Profitability Increased
Previous 15.31%
Current 16.93%
Delta 1.62% R And D Intensity Increased
Previous 1.47%
Current 1.57%
Delta 0.10% Sbc Intensity Decreased
Previous 0.69%
Current 0.59%
Delta -0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.